News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Kathleen A. Fairman, MA

Articles by Kathleen A. Fairman, MA

Utilization Outcomes and Patient Cost Sharing

ByKathleen A. Fairman, MA,Michael E. Chernew, PhD,Joseph P. Newhouse, PhD

September 14th 2008

Course of Antidepressant Treatment with Tricyclic Versus Selective Serotonin Reuptake Inhibitor Agents: A Comparison in Managed Care and Fee-for-Service Environments

ByKathleen A. Fairman, MA,Fred Teitelbaum, PhD,Wayne C. Drevets, MD,Gretchen Engquist, PhD,Jerold J. Kresman, MD,Marija J. Norusis, PhD

March 1st 1997

Latest Updated Articles

Course of Antidepressant Treatment with Tricyclic Versus Selective Serotonin Reuptake Inhibitor Agents: A Comparison in Managed Care and Fee-for-Service Environments
Published: March 1st 1997 | Updated:
Utilization Outcomes and Patient Cost Sharing
Published: September 14th 2008 | Updated:

Trending on AJMC

FDA Approves Inebilizumab for Generalized Myasthenia Gravis

Single-Dose Oral Antibiotic Zoliflodacin Treats Drug-Resistant Gonorrhea

Clascoterone 5% Delivers Strong Phase 3 Results for Androgenetic Alopecia

Cardiotoxicity Remains a Concern as Breast Cancer Survival Rates Improve: Eric H. Yang, MD

5 Key Oncology FDA Approvals From November

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.